Identification and validation of a linear protective neutralizing epitope in the β-pore domain of alpha toxin.

Abstract

The plethora of virulence factors associated with Staphylococcus aureus make this bacterium an attractive candidate for a molecularly-designed epitope-focused vaccine. This approach, which necessitates the identification of neutralizing epitopes for incorporation into a vaccine construct, is being evaluated for pathogens where conventional approaches have failed to elicit protective humoral responses, like HIV-1 and malaria, but may also hold promise for pathogens like S. aureus, where the elicitation of humoral immunity against multiple virulence factors may be required for development of an effective vaccine. Among the virulence factors employed by S. aureus, animal model and epidemiological data suggest that alpha toxin, a multimeric β-pore forming toxin like protective antigen from Bacillus anthracis, is particularly critical, yet no candidate neutralizing epitopes have been delineated in alpha toxin to date. We have previously shown that a linear determinant in the 2β2-2β3 loop of the pore forming domain of B. anthracis protective antigen is a linear neutralizing epitope. Antibody against this site is highly potent for neutralizing anthrax lethal toxin in vitro and for protection of rabbits in vivo from virulent B. anthracis. We hypothesized that sequences in the β-pore of S. aureus alpha toxin that share structural and functional homology to β-pore sequences in protective antigen would contain a similarly critical neutralizing epitope. Using an in vivo mapping strategy employing peptide immunogens, an optimized in vitro toxin neutralization assay, and an in vivo dermonecrosis model, we have now confirmed the presence of this epitope in alpha toxin, termed the pore neutralizing determinant. Antibody specific for this determinant neutralizes alpha toxin in vitro, and is highly effective for mitigating dermonecrosis and bacterial growth in a mouse model of S. aureus USA300 skin infection. The delineation of this linear neutralizing determinant in alpha toxin could facilitate the development of an epitope-focused vaccine against S. aureus.

• Authors: Jon Oscherwitz, Kemp B Cease
• Journal: PloS one (PLoS One) Vol. 10 Issue 1 Pg. e0116882 ( 2015) ISSN: 1932-6203 [Electronic] United States
• PMID: 25635901 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S.)

Chemical References

• Antibodies, Bacterial
• Antibodies, Neutralizing
• Bacterial Proteins
• Bacterial Toxins
• Bacterial Vaccines
• Epitopes
• Exotoxins

Topics

• Amino Acid Sequence
• Animals
• Antibodies, Bacterial (physiology)
• Antibodies, Neutralizing (physiology)
• Antibody-Dependent Cell Cytotoxicity
• Bacterial Proteins (chemistry, immunology)
• Bacterial Toxins (chemistry, immunology)
• Bacterial Vaccines (immunology)
• Epitopes (immunology)
• Exotoxins (chemistry, immunology)
• Female
• Humans
• Immunization, Passive
• Jurkat Cells
• Mice, Inbred BALB C
• Mice, Inbred C57BL
• Molecular Sequence Data
• Protein Structure, Tertiary
• Rabbits
• Sequence Homology, Amino Acid
• Staphylococcal Infections (immunology, microbiology, prevention & control)
• Staphylococcal Skin Infections (immunology, microbiology, prevention & control)
• Staphylococcus aureus (immunology)